Belgium - Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by All Financing Schemes
Since 2014, Belgium Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by All Financing Schemes increased 2.9% year on year. With €606.09 Per Capita in 2019, the country was number 4 among other countries in Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by All Financing Schemes. Belgium is overtaken by Germany, which was ranked number 3 with €668.01 Per Capita and is followed by Luxembourg at €593.97 Per Capita. Switzerland ranked the highest with €1,048.7 Per Capita in 2019, +2.6% compared to 2018. Latvia witnessed the best average annual growth at +7.4% per year, while Greece witnessed the worst performance at -0.5% per year.
Loading...
| Date | Euros Per Capita |
|---|---|
| 2019 | 606.09 |
| 2018 | 605.18 |
| 2017 | 577.49 |
| 2016 | 559.39 |
| 2015 | 553.43 |
Download all data from 2003 to 2019
How does Belgium rank in Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by All Financing Schemes?
| # | 33 Countries | Euros Per Capita | Last | YoY | 5‑years CAGR | |
|---|---|---|---|---|---|---|
| 1 |
#1
Switzerland
|
1,048.70 | 2019 | +2.6 % | +4.7 % | View data |
| 2 |
#2
Liechtenstein
|
860.32 | 2019 | +3.0 % | +2.4 % | View data |
| 3 |
#3
Germany
|
668.01 | 2019 | +1.7 % | +3.2 % | View data |
| 4 |
#4
Belgium
|
606.09 | 2019 | +0.1 % | +2.9 % | View data |
| 5 |
#5
Luxembourg
|
593.97 | 2019 | +0.9 % | +0.8 % | View data |